Live from the NIH registry
Studies recruiting near Oklahoma City right now
Top 25 of 647 recruiting studies, sorted by proximity — each links to its official registry page
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Medtronic
Evaluation of the MuSICCA for Measuring Awareness
Disorder of Consciousness
N/A
Observational 80 participants sought
Bethany Children's Health Centre — Bethany, Oklahoma (7.6 mi)
· Sponsor: The Children's Trust, United Kingdom
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
Post Operative Surgical Site Infection
Phase 3
Interventional 600 participants sought
University of Oklahoma College of Medicine — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Major Extremity Trauma Research Consortium
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
University of Oklahoma - Health Sciences Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Syndax Pharmaceuticals
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: NRG Oncology
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Sameek Roychowdhury
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer site in Oklahoma City, OK — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Mediar Therapeutics
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Thrombotic Thrombocytopenic Purpura, Congenital Thrombotic Thrombocytopenic Purpura
N/A
Observational 450 participants sought
University of Oklahoma Health Sciences Center, Department of Medicine, PO Box 26901 — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Insel Gruppe AG, University Hospital Bern
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Oklahoma Heart Hospital — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: NRG Oncology
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Advanced or Metastatic Colorectal Cancer
Phase 1, Phase 2
Interventional 225 participants sought
Stephenson Cancer Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Janssen Research & Development, LLC
Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction
Heart Failure With Preserved Ejection Fraction, Concentric Hypertrophy
N/A
Interventional 105 participants sought
Oklahoma Heart Hospital — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Attitudes and Perceptions Attitudes and Smoking Perceptions in the Real Environment -II
Cigarillo Flavor
N/A
Interventional 190 participants sought
TSET Health Promotion Research Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: University of Oklahoma
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: NRG Oncology
Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers
Lung Cancers
N/A
Observational 350 participants sought
Site 101 — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Everest Detection, Inc.
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Digestive Disease Specialists Inc — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Janssen Research & Development, LLC
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Tekton Research - Yukon, OK — Yukon, Oklahoma (14.3 mi)
· Sponsor: Ardelyx
The Role of Dietary Fiber in Mitigating Sarcopenia Risk in Head and Neck Cancer
Head and Neck Cancers
N/A
Observational 59 participants sought
Stephenson Cancer Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: University of Oklahoma
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
Platinum-sensitive Relapsed Epithelial Ovarian Cancer, Platinum-sensitive Relapsed Fallopian Tube Cancer
Phase 3
Interventional 600 participants sought
Research Site — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: AstraZeneca
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Overweight , Obesity, Adults
Phase 2
Interventional 220 participants sought
Lynn Health Science Institute — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Alveus Therapeutics, Inc.
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer
Phase 1, Phase 2
Interventional 890 participants sought
Stephenson Cancer Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Regeneron Pharmaceuticals
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
Oklahoma University Medical Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Novartis Pharmaceuticals
Ketamine for Post-operative Analgesia in Hemorrhoidectomy
Hemorrhoids
Phase 4
Interventional 100 participants sought
University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: University of Oklahoma
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Mercy Hospital Oklahoma City — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology